40 participants
Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor Burden
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-15
- Start Date:
- 2025-04-01
- Completion:
- 2028-08-31
Conditions
- Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- Lymphoma
Interventions
- DRUG
No Results Yet